A detailed history of Knights Of Columbus Asset Advisors LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Knights Of Columbus Asset Advisors LLC holds 1,537 shares of ABBV stock, worth $275,799. This represents 0.02% of its overall portfolio holdings.

Number of Shares
1,537
Previous 1,506 2.06%
Holding current value
$275,799
Previous $258,000 17.44%
% of portfolio
0.02%
Previous 0.02%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$163.84 - $199.33 $5,079 - $6,179
31 Added 2.06%
1,537 $303,000
Q2 2024

Jul 30, 2024

SELL
$154.79 - $180.76 $229,708 - $268,247
-1,484 Reduced 49.63%
1,506 $258,000
Q1 2024

May 10, 2024

BUY
$159.82 - $182.1 $171,486 - $195,393
1,073 Added 55.97%
2,990 $544,000
Q4 2023

Jan 31, 2024

SELL
$137.6 - $154.97 $5,091 - $5,733
-37 Reduced 1.89%
1,917 $297,000
Q3 2023

Nov 01, 2023

BUY
$133.59 - $154.65 $6,145 - $7,113
46 Added 2.41%
1,954 $291,000
Q2 2023

Jul 31, 2023

BUY
$132.51 - $164.9 $5,697 - $7,090
43 Added 2.31%
1,908 $257,000
Q1 2023

May 01, 2023

SELL
$144.61 - $166.54 $11,424 - $13,156
-79 Reduced 4.06%
1,865 $297,000
Q4 2022

Jan 31, 2023

BUY
$138.31 - $165.87 $20,884 - $25,046
151 Added 8.42%
1,944 $314,000
Q3 2022

Nov 10, 2022

SELL
$134.21 - $153.93 $16,373 - $18,779
-122 Reduced 6.37%
1,793 $241,000
Q2 2022

Aug 12, 2022

SELL
$137.62 - $174.96 $6,192 - $7,873
-45 Reduced 2.3%
1,915 $294,000
Q1 2022

May 16, 2022

SELL
$131.98 - $163.75 $407,950 - $506,151
-3,091 Reduced 61.2%
1,960 $318,000
Q4 2021

Feb 11, 2022

BUY
$107.43 - $135.93 $4,404 - $5,573
41 Added 0.82%
5,051 $684,000
Q3 2021

Nov 10, 2021

BUY
$106.4 - $120.78 $533,064 - $605,107
5,010 New
5,010 $540,000
Q4 2017

Feb 13, 2018

SELL
$89.56 - $98.21 $0 - $0
0 Closed
0 $0
Q3 2017

Nov 09, 2017

BUY
$69.85 - $89.22 $0 - $0
0
0 $0

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $317B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Knights Of Columbus Asset Advisors LLC Portfolio

Follow Knights Of Columbus Asset Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Knights Of Columbus Asset Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Knights Of Columbus Asset Advisors LLC with notifications on news.